Literature DB >> 4689325

Binding of cis- and trans-dichlorodiammineplatinum(II) to nucleosides. I. Location of the binding sites.

S Mansy, B Rosenberg, A J Thomson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4689325     DOI: 10.1021/ja00786a045

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  14 in total

Review 1.  New drugs under clinical evaluation in the United States.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  The exocyclic amino group of adenine in PtII and PdII complexes: a critical comparison of the X-ray crystallographic structural data and gas phase calculations.

Authors:  Radu Silaghi-Dumitrescu; Béla Mihály; Timea Mihály; Amr A A Attia; Pablo J Sanz Miguel; Bernhard Lippert
Journal:  J Biol Inorg Chem       Date:  2017-03-17       Impact factor: 3.358

Review 3.  A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.

Authors:  B J Foster; B J Harding; M K Wolpert-DeFilippes; L Y Rubinstein; K Clagett-Carr; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Identification of GAPDH as a protein target of the saframycin antiproliferative agents.

Authors:  Chengguo Xing; Jacob R LaPorte; Joseph K Barbay; Andrew G Myers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

5.  Cisplatin interaction with phosphatidylserine bilayer studied by solid-state NMR spectroscopy.

Authors:  Magnus Jensen; Morten Bjerring; Niels Chr Nielsen; Willy Nerdal
Journal:  J Biol Inorg Chem       Date:  2009-09-19       Impact factor: 3.358

6.  Separation of platinated derivatives of nucleic acid bases on Sephadex G10.

Authors:  R Oliński; Z Walter
Journal:  Mol Biol Rep       Date:  1983-08       Impact factor: 2.316

7.  Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples.

Authors:  B Royer-Pokora; L K Gordon; W A Haseltine
Journal:  Nucleic Acids Res       Date:  1981-09-25       Impact factor: 16.971

8.  Comparison of MS/MS methods for characterization of DNA/cisplatin adducts.

Authors:  Zhe Xu; Jared B Shaw; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2012-12-20       Impact factor: 3.109

9.  Platinum binds selectively to phosphorothioate groups in mono- and polynucleotides: a general method for heavy metal staining of specific nucleotides.

Authors:  K G Strothkamp; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Similar binding of the carcinostatic drugs cis-[Pt(NH3)2Cl2] and [Ru(NH3)5Cl] Cl2 to tRNAphe and a comparison with the binding of the inactive trans-[Pt(NH3)2Cl2] complex - reluctance in binding to Watson-Crick base pairs within double helix.

Authors:  J R Rubin; M Sabat; M Sundaralingam
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.